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Sleeping Sickness or Human African Trypanosomiasis
(HAT), which is a fatal disease if left untreated, is caused
by subspecies of the extracellular parasite, Trypanosoma
brucei (Tb), spread by the tsetse fly in sub-Saharan Africa.
Two stages of the disease are recognized: Stage 1, in which
the parasites appear in the hemolymphatic system and
Stage 2, presented by severe signs of brain involvement.
The diagnostic criteria for Stage 2 are under debate and
rely on finding trypanosomes and/or an elevated number
of white blood cells (WBC) in the cerebrospinal fluid.
Patients in Stage 1 are treated with drugs with poor pene-
tration of the blood-brain barrier (BBB), whereas arsenic
compounds that permeate the BBB, but which can be
lethal, are widely used for Stage 2 patients. Disclosing
mechanisms by which the parasites spread from the blood
vessels into the brain could contribute to develop biomar-
kers for better staging of the diseases and treatment.
Data obtained from studies of experimental rodent mod-
els of African trypanosomiasis will be presented, showing
that invasion of the parasites into the brain is a multi-step
process, similar to that of WBC, and regulated by host-
derived molecules, which can be analyzed in body fluids.
During early stage of infection, the rodent pathogenic Tb
brucei parasites and WBC appear in the choroid plexus and
the circumventricular organs that lack a BBB. Certain of
the signs of hypothalamic dysfunctions in the disease may
be related to release of inflammatory molecules in these
organs. At a later stage, the parasites and WBC penetrate
the BBB. Studies using minocycline, which impedes pas-
sage of WBC into the brain, and different strains of mice,
have shown that loss of weight and death is related to
brain invasion and not to the systemic infection of the
trypanosomes.
During the infection, trypanosomes trigger release of
interferon (IFN)-γ, which plays an important role to per-
mit the trypanosomes to cross the parenchymal basement
membranes of the BBB. Array studies show up-regulated
expression of the IFN-γ-inducible chemokine CXCL10.
Mice with deleted genes encoding this chemokine show
less parasite neuroinvasion and weight loss, but no
reduced level of parasitemia. IFN-γ affects also synaptic
functions in neuronal circuits of the brain. The level of
IFN-γ and CXCL10 in the cerebrospinal fluids correlates
with severity of the disease in patients with HAT.
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